A severe injury can trigger an inflammation response and excessive response can cause multiple organ failure. HMGB1 is an early inflammation mediator in sterile injury and a late inflammation mediator in infection. It is an impor-tant mediator in severe sepsis and always associated with the severity of organ failure. Previous studies showed that the administration of systemic lidocaine could inhibit the expression of HMGB1 on septic mice with musculoskeletal injury. Nine male adult Balb/c mice were grouped by simple random sampling method into three groups of intravenous lidocaine injection dosages: 2 mg/kg, 3 mg/kg, 4 mg/kg. Musculoskeletal injury was done by breaking the left femo-ral bone in a close manner. Peripheral blood sampling was done 4 hours after injury and 2 hours after lidocaine therapy. To evaluate the expression level of HMGB1 mRNA, RT-PCR was used. The result of our study showed that intravenous lidoaine administration on the 3 groups could decrease the level of HMGB1. In conclusion, lidocaine hold an important role in clinical diseases by inhibiting HMGB1.
Introduction
A severe injury can trigger an inflammation response and excessive response can produce multiple inflammation cytokines that can activate the systemic response in term of systemic inflammation response syndrome (SIRS). SIRS can affect the vascular permeability, and the function of heart, lungs, liver, kidneys, intestines, and other organs; and induce metabolic changes that can cause multiple organ failure (MOF), septic shock, and even death [1] [2] [3] .
Previous study showed that inflammation cytokine like high mobility group box 1 (HMGB1) was always associated with organ worsening [2] [4] . HMGB1 is a nuclear protein that has been known as transcription and growth factor [5] [6] [7] .
HMGB1 is an important inflammation mediator in sepsis and the level is increased in major surgery procedures [8] [9] [10] .
Lidocaine is a local anaesthetic from amide group that has been long known and used in clinical practice to prevent surgical pain and reduce the pain from disease proccess. Lidocaine also has anti-arrythmic and anti-inflammation properties. In the last decades, the anti-inflammation property of lidocaine had been used to treat septic mice and protect against organ failure from its ability to inhibit the expression of macrophage HMGB1 [11] - [16] .
The purpose of this study is to analyze the effectivity of systemic lidocaine dosages of 2 mg/kg body weight, 3 mg/kg body weight, and 4 mg/kg body weight on the expression of mice Balb/c mice with closed femoral fracture.
Material and Methods
This is a longitudinal laboratory experiment on animals, using nine Balb/c mice. Firstly, 0.3 ml venous blood was taken from every mice' tails to evaluate the initial expression of HMGB1 mRNA (Group I), then the mice were anaesthesized by injecting 50 mgs/kg body weight of Ketamine intraperitoneally. After that, mice left femoral bone were broken in a close manner using 2 Kocher, and after 4 hours 0.3 cc blood was taken (Group II). Mice were injected with systemic lidocaine every 2 hours for 24 hours from the tail veins with dosages of 2 mgs/kg body weight, 3 mgs /kg body weight, and 4 mgs/kg body weight. Two hours after lidocaine therapy, 0.3 cc mice blood were drawn again for the third examination (Group III). All blood samples were mixed with L6 solution to be processed into nucleic acid extract and stored −80˚C temperature.
Real-Time Polymerase Chain Reaction (RT-PCR) Analysis
RT-PCR analysis was done by making specific primers PCR mixture as much as The data was analyzed using ANOVA test or its alternative with significance level of p < 0.05.
Results
The mean weight of the 9 mice from the 3 experimental mice was: control group 36.2 grams, intervention group 37.466 grams, and therapeutic group 38.8 grams.
There was no significant difference in the mice weight in the 3 experimental gro- 
Discussion
Inflammation response is a very complex series of events involving many inflammation, anti-inflammation process, humoral and celullar process that will cause metabolic abnormality in systemic circulation [3] [7] . Severe injury will stimulate the body immune system to produce inflammatory cytokines, such as TNF α, IL1, and HMGB1 [20] [4].
Data of our study showed that HMGB1 mRNA expression can be detected before mice underwent close femoral fracture, and the level will be increased after the mice underwent left femoral bone fracture. Increased level of HMGB1 mRNA expression was detected 4 hours after left bone fracture. The result of this study was consistent with previous studies which showed that increased HMGB1 level can be detected on the end of surgery and can last up to 2 days after liver resection surgery or on the first day of heart bypass procedure.
Lidocaine is a traditional local anaesthetic that has been long used as analgesic and anti-arrythmia. The anti inflammatory property of lidocaine has long been known and proved useful in the treatment of chronic diseases, such as rheumatic arthritis and colitis [10] [11] [12] [13] [14] .
The result of our study showed that the administration of systemic lidocaine in dosages of 2 mgs/kg body weight, 3 mgs/kg body weight, and 4 mgs/kg body weight every 2 hours for 24 hours after musculoskeletal injury can decrease the expression of HMGB1 mRNA up to the initial level before mice underwent musculoskeletal injury.
The result of lidocaine therapy in this study was consistent with previous studies on septic experimental animals which was induced with lipopolysaccharides [26] [27] [28] . We conclude that lidocaine is useful and has an important role in the management of many clinical diseases by inhibiting the production and release of HMGB1 in pathological condition.
